View in EDS HTML Full Text PDF Full Text

Response to nivolumab as an immune checkpoint inhibitor rechallenge for esophageal squamous cell carcinoma with PD-L1 amplification: a case report.

Saved in:
Bibliographic Details
Title: Response to nivolumab as an immune checkpoint inhibitor rechallenge for esophageal squamous cell carcinoma with PD-L1 amplification: a case report.
Authors: Kodama H; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.; Cancer Chemotherapy Center, Osaka Medical and Pharmaceutical University, Osaka, Japan.; Department of Gastroenterology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Masuishi T; Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi 464-8681, Japan., Ishizuka Y; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Sakakida T; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Honda K; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Narita Y; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Taniguchi H; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Kadowaki S; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Ando M; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Hosoda W; Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya, Japan., Muro K; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
Source: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2026 Jun 16; Vol. 18, pp. 17588359261451859. Date of Electronic Publication: 2026 Jun 16 (Print Publication: 2026).
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42317255
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Response to nivolumab as an immune checkpoint inhibitor rechallenge for esophageal squamous cell carcinoma with PD-L1 amplification: a case report.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kodama+H%22">Kodama H</searchLink>; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.; Cancer Chemotherapy Center, Osaka Medical and Pharmaceutical University, Osaka, Japan.; Department of Gastroenterology, Osaka Medical and Pharmaceutical University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Masuishi+T%22">Masuishi T</searchLink>; Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi 464-8681, Japan.<br /><searchLink fieldCode="AU" term="%22Ishizuka+Y%22">Ishizuka Y</searchLink>; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.<br /><searchLink fieldCode="AU" term="%22Sakakida+T%22">Sakakida T</searchLink>; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.<br /><searchLink fieldCode="AU" term="%22Honda+K%22">Honda K</searchLink>; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.<br /><searchLink fieldCode="AU" term="%22Narita+Y%22">Narita Y</searchLink>; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.<br /><searchLink fieldCode="AU" term="%22Taniguchi+H%22">Taniguchi H</searchLink>; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.<br /><searchLink fieldCode="AU" term="%22Kadowaki+S%22">Kadowaki S</searchLink>; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.<br /><searchLink fieldCode="AU" term="%22Ando+M%22">Ando M</searchLink>; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.<br /><searchLink fieldCode="AU" term="%22Hosoda+W%22">Hosoda W</searchLink>; Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya, Japan.<br /><searchLink fieldCode="AU" term="%22Muro+K%22">Muro K</searchLink>; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101510808%22">Therapeutic advances in medical oncology</searchLink> [Ther Adv Med Oncol] 2026 Jun 16; Vol. 18, pp. 17588359261451859. <i>Date of Electronic Publication: </i>2026 Jun 16 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Case Reports; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage%22">Sage </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101510808 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1758-8340 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217588340%22">17588340 </searchLink><i>NLM ISO Abbreviation: </i>Ther Adv Med Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42317255
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/17588359261451859
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 17588359261451859
    Titles:
      – TitleFull: Response to nivolumab as an immune checkpoint inhibitor rechallenge for esophageal squamous cell carcinoma with PD-L1 amplification: a case report.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kodama H
      – PersonEntity:
          Name:
            NameFull: Masuishi T
      – PersonEntity:
          Name:
            NameFull: Ishizuka Y
      – PersonEntity:
          Name:
            NameFull: Sakakida T
      – PersonEntity:
          Name:
            NameFull: Honda K
      – PersonEntity:
          Name:
            NameFull: Narita Y
      – PersonEntity:
          Name:
            NameFull: Taniguchi H
      – PersonEntity:
          Name:
            NameFull: Kadowaki S
      – PersonEntity:
          Name:
            NameFull: Ando M
      – PersonEntity:
          Name:
            NameFull: Hosoda W
      – PersonEntity:
          Name:
            NameFull: Muro K
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 16
              M: 06
              Text: 2026 Jun 16
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 1758-8340
          Numbering:
            – Type: volume
              Value: 18
          Titles:
            – TitleFull: Therapeutic advances in medical oncology
              Type: main
ResultId 1